[
    {
        "type": "text",
        "text": "Association of echocardiographic left ventricular structure and -344C/T aldosterone synthase gene variant: A meta-analysis ",
        "text_level": 1,
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Lijuan Wang', Jiapeng Zhou2,3, Bei Zhang', Hao Wang', Mei Li', Qiuli Niu',Yubao Chen², Runsheng Chen³ and Shaojun Wen' ",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Abstract ",
        "text_level": 1,
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Background: Aldosterone synthase (CYPIIB2)isoneof the most studied candidate genes related to essntial hypertension (EH)andleftventricularhypertrophy(LVH).Somestudieshavefocusedontherelationship between-344C/Tpolymorphism (rsl79998)inthe CYPIIB2 geneandLVH,but theresultsare controversial.This meta-analysis is purposed toreveal the relationship between the-344C/Tandthe left ventricularstructureandfunction,including leftventricularenddiastolic dimension (LVEDD),left ventricular end systolicdiameter(LVESD),left ventricular mass/left ventricular mass index (LVM/ LVMI),left ventricular posterior wallthickness (LVPWT),and interventricular septal wallthickness (IVS). ",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Methods:Aliterature search of PubMed and Embase databases was conducted on articles published before January 27, 2014. The odds ratios with $9 5 \\%$ confidence intervals were calculated. Heterogeneity analyses were performed using metaregresion.Tests for publication bias were also performedand biased studies should be removed fromsubsequent analyses. Results:There were 20 studies with atotal of 6780 subjects meeting the inclusion criteria.The main finding was that concentration levelsofLVEDDandLVESD were higherin CChomozygous individuals than inTThomozygous individuals in thewhole group.Inthe Asian subgroup,TT homozygous individuals hadlarger IVS than CC homozygous individuals. In the Caucasian normotension subgroup，CC homozygous individuals had larger LVM/LVMl than TT homozygous individuals.In the Asian esential hypertensionsubgroup,TThomozygous individuals had larger LVPWTvalues than CC homozygous individuals. ",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Conclusions: The present findings support the hypothesis that CC homozygous individuals may have greater left ventricular diameters (LVEDD and LVESD) regardless of their ethnicities or physical conditions. ",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Keywords ",
        "text_level": 1,
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Cardiovascular disease,left ventricular structure, CYPIIB2 -344C/T,echocardiography, meta-analysis ",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Background ",
        "text_level": 1,
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Left ventricular hypertrophy (LVH) is not only an inevitable adaptation to increased hemodynamic load in hypertension, but it is one of the most important, strongest,and independent risk factors for cardiovascular morbidity and mortality. It has been postulated that left ventricular growth and structure have complex interactions with genetic, environmental, and lifestyle control factors.1LVHwas first deemeda complication of hypertension 150 years ago at autopsy, and by chest X-ray in the following years. Over the years,electrocardiography has become the first choice for thedefinite diagnosis ofLVH, particularly in hypertensives.²LVH was diagnosed mainly by left ventricular mass (LVM) or left ventricular mass index (LVMI) in ultrasonic cardiography.3 ",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Between $30 \\%$ and $70 \\%$ of the population variability in LVH appears to be genetically determined.4-6 In this way, focusing on the specific genes that influence quantitative variation in left ventricular structure is merited, and the findings may generate insights into the pathogenesis of cardiac hypertrophy. The renin-angiotensin-aldosterone system (RAAS) has been shown to influence myocardial growth independently of hypertension,and it has been speculated that the polymorphisms of genes coding this system may explain the heritability ofLVH. ",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Aldosterone synthase (CYP1lB2） is a key enzyme in RASS.In 1998,Kupari et al. originally reported the -344C/T polymorphism (rs1799998） in CYP11B2 was associated with left ventricular size and LVM.7 Then a large number of studies seeking to link the -344C/T poly morphism to LVH were conducted in individuals of different races and ethnic groups using different statistical models in various left ventricular structure and function indicators,but the results have often been unreproducible.8-13 A meta-analysis regarding the relationship between $- 3 4 4 \\mathrm { C / T }$ and left ventricular size was published in 2008. This meta-analysis covered14 studies that were performed mainly on Europeans,but in recent years,many studies covering other ethnic groups,especiallyAsians,have been published.14 In recent studies, sample size is much greater thanpreviously.Here,all availabledatawere collected and the influence of the $- 3 4 4 \\mathrm { C / T }$ polymorphism on the left ventricular structure and function,such as LVM,left ventricular end diastolic dimension (LVEDD),and left ventricular end systolic diameter(LVESD),was systematically evaluated. ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Methods ",
        "text_level": 1,
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Literaturesearch ",
        "text_level": 1,
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "To identify all the studies that addressed the association between CYP11B2 -344C/T polymorphism and left ventricular structure and function,a systematic computerized literature search of PubMed and Embase databases (up to March 5,2014) was conducted using the following keywords and Medical Subject Headings (MeSH) terms: (aldosterone synthase or CYP1lB2） and (gene(s） or variant(s) or polymorphism(s) or allele(s))and (left ven tricular).Searchresultswerelimitedto studiesonhuman subjects.We searched the articles without language limitation.The full text of the retrieved studies was scrutinized, and all of the references cited in the articles were searched to identify potentially relevant studies.All the articles were organized by year of publication and first author. Theywere entered into a dedicated literature database. ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Selection criteria. The studies had to meet all the following criteria.Inclusion criteria:(1) Thearticleshadto include at least one of the following echocardiographicallymeasured traits:LVM,LVMI,left ventricular end diastolic volume index (LVEDVI),LVEDD, left ventricular end systolic volume index (LVESVI),LVESD,left ventricular posterior wall thickness (LVPWT),and interventricular septal wall thickness (IVS).(2) Only research articles and clinical trials were included.(3)Eligible articles had to provide sufficient information to extract or calculate for the CYP11B2 -344C/T genotype number of subjects and the mean and standard deviation(SD）of continuous left ventricular structure/function indicators.(4) If the eligible article was a case-control study,both case and control groups had to be involved and the genotype distribution of control population had to obey the Hardy-Weinberg equilibrium (HWE). Duplicates were removed. Exclusion criteria: Studies involving non-echocardiographically measured phenotypes and studies assessed by magnetic resonance imaging were excluded. Studies in patients with specific disorders,such asrenovascular diseases and renal dysfunction,were ignored.Data based on follow-up studies involving pharmacological interventions according to $- 3 4 4 \\mathrm { C / T }$ were also excluded. ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Data extraction. Two investigators(LW, JZ) read through allthe researcharticlesand extractedand calculated the required statistics and relevant information independently. Inconsistencies were discussed between the two investigators until a consensus was reached on all items.For all studies included, the following information was collected: year of publication, first author,country,journal, racial makeup of the study population, demographics, sex, age, sources of recruitment, character of participants (e.g. kinds of diseases or healthy),allelic and genotypic frequencies of the $- 3 4 4 \\mathrm { C / T }$ ,left ventricular phenotypes corresponding to $- 3 4 4 \\mathrm { C / T }$ ，and confirmation of diagnosis.If allele frequencies were not given, they were calculated from the corresponding genotype frequencies of the case and the control groups.All the eligible studies were ordered by year of publication and then were entered into a dedicated literaturedatabase.Mean $\\pm$ SD was used for continuous variables.The methodology of CYP11B2-344C/T geno typing was treated as a possible confounding factor in the statistical analysis. ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Statistical analysis.Software R(http://cran.stat.sfu.ca/) and Review Manager 5.0 (Oxford, UK)were used to enter extracted data into a manageable database and for subsequent statistical analyses.Yu's method was used to calculate themean standardizeddifference,which was used to assess inter-group differences independent of the unit of measurement.4,14 ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Heterogeneity was tested using $I$ square $( I ^ { 2 } )$ . We used a random-effects model to conduct all the comparisons.15 ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "For the meta-regression, the dominant genetic model and homozygote comparison model were mainly used.16 Dominant genetic models were used to compare the phenotype values of $\\mathrm { T C + C C }$ genotype individuals to that of TT genotype individuals.Homozygote comparison models were used to compare the phenotype values of CC genotype individuals to those of TT genotype individuals.These values were found to be equal to those of an additive genetic model with selective and extreme genotypes. Empirically, the studieswere regrouped into subsets by ethnicity and physical condition and the meta-regression analyses were repeated for the new subsets. ",
        "page_idx": 1
    },
    {
        "type": "image",
        "img_path": "images/60d0df90f2c5db5673242936fa262175619e289f695539444c483d835bdc6534.jpg",
        "img_caption": [
            "FigureI.Flowchart of studies included in thisanalysis. "
        ],
        "img_footnote": [],
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "Sensitivity analyses were performed to evaluate the reliability of meta-regression results and to detect any uncertainty.l7 Sensitivity analyses were conducted by sequentially deleting a single study each time in an attempt to identify the influence of the individual data sets on pooled effect sizes.If the point estimate of the combined effect size with one study omitted lay outside the $9 5 \\%$ confidence intervals (CIs) of the estimate with all available studies,then the study in question was considered to have excessive influence and was omitted. In addition,a regression with confounding factors as covariates was also conducted, and $p$ values $< 0 . 1$ were considered statistically significant.4 ",
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "Publication bias was assessed using visual inspection of funnel plots and the Egger regression intercept method. $P$ values $< 0 . 0 5$ were considered statistically significant. Asymmetrical funnel plots and $p$ values $< 0 . 0 5$ of the corresponding Egger's test suggested obvious publication bias.18,19 ",
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "Results ",
        "text_level": 1,
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "Study characteristics ",
        "text_level": 1,
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "Figure 1 shows the process of literature searching and filtering.The search terms listed in the Methods section above were used,and 917 hits were generated in the PubMedandEmbase electronicdatabases.Reviews of the titles found that 297 were not in humans, four were comments and responses,and 98 were reviews.Reviews of the abstracts resulted in exclusion of 497 studies because they were outside the focus of the present work.A full paper review of 37 studies was performed.Among these,17 were excluded because their data were duplicated ( $( n = 1 )$ ） or incomplete $( n = 1 6 )$ ).Because data regardingLVM,IVS, LPWD,LVEDD,and LVESD from a study published by Rao et al.in 2oo3 was also included in the study published bythe same team in 2oo4, the latter studywas included in the analysis.20,21 The remaining 16 studies contained no matched phenotype or genotype data on any left ventricular echocardiography indicator.Ultimately, 2O studies met the criteria.Characteristics of the 2O included studies are listed in Table 1.Most of them were published from 1998 to 2007,one in 2011,and one in 2012.Thirteen studies were performed on Caucasians,six on Asians,and one study ona United States(US) population.Three-quarters of the studies were hospital based.9,11-13,22-31 One-quarter were population based.7,8,32.33,25 Eighteen studies used patients who suffered from cardiovascular disease (CVD). There were three ethnicities:13 studies included Caucasian subjects,six studies includedAsian subjects,and one study consisted of279 white American subjects.HWE tests were performed for each study,and all were found to be in equilibrium. ",
        "page_idx": 2
    },
    {
        "type": "table",
        "img_path": "images/5a607a7372e81c72ada23d4b520b4415aae218d6b04c735ed8081127ae17e552.jpg",
        "table_caption": [
            "Table I.Characteristics of the included studies.20 "
        ],
        "table_footnote": [
            "AF:atrialfibriio;Cdasass;:daedatstilrtsin;Herod thy;HF:arte;tetricatall;Dftdstlaeftadl diameter;Mt;:tasi;:taall;Moo NM:ormotesion;N.:umberofarticipantsinteud;CR-RFP:lmerasecaineactiotrictiofragmentgtholymosm;U United States. "
        ],
        "table_body": "<html><body><table><tr><td>First author, year</td><td>No.</td><td>Country</td><td>Ancestry</td><td>Design</td><td>DNA genotype</td><td>Character of subjects</td><td>Left ventricular structure phenotype</td></tr><tr><td>Kupari,7 1998</td><td>84</td><td>USA</td><td>Caucasian</td><td>Population based</td><td>PCR-RFLP</td><td>No CVD</td><td>LVM, IVS,LVPWT, LVEDD,LVESD</td></tr><tr><td>Schunkert,32 1999</td><td>1669</td><td>Germany</td><td>Caucasian</td><td>Population based</td><td>PCR-RFLP</td><td>Community included EH</td><td>LVMI, IVS, LVEDD, LVESD, LVPWT</td></tr><tr><td>Tamaki,22 1999</td><td>136</td><td>Japan</td><td>Asian</td><td>Hospital-based</td><td>PCR-RFLP</td><td>Healthy and EH</td><td>LVEDD, LVESD, IVS, LVPWT</td></tr><tr><td>Schunkert,33 2000</td><td>606</td><td>Germany</td><td>Caucasian</td><td>Population based</td><td>PCR-RFLP</td><td>MI</td><td>LVM/LVMI, IVS, LVEDD, LVESD,</td></tr><tr><td>Patel,232000</td><td>279</td><td>USA</td><td>Others</td><td>Hospital based</td><td>PCR-RFLP</td><td>HCM</td><td>LVPWT LVMI, IVS,LVEDD</td></tr><tr><td>Delles, 2001</td><td>240</td><td>Germany</td><td>Caucasian</td><td>Population</td><td>PCR-RFLP</td><td>Mildly EH and</td><td>LVM, IVS,LVEDD,</td></tr><tr><td>Ortlepp,24 2001</td><td>105</td><td>Germany</td><td>Caucasian</td><td>based Hospital based</td><td></td><td>healthy</td><td>LVESD,LVPWT Symptomatic calcific LVM/LVMI, LVEDD,</td></tr><tr><td>Kurland,25 2002</td><td>168</td><td>Sweden</td><td>Caucasian</td><td></td><td>Hospital basedAllele-specific</td><td>aortic stenosis EH</td><td>IVS, LVPWT LVMI</td></tr><tr><td>Takai,2 2002</td><td>201</td><td>Japan</td><td>Asian</td><td>Hospital based</td><td>oligonucleotides PCR-RFLP</td><td>DCM</td><td>LVEDVI,EI</td></tr><tr><td>Sarzani,26 2003</td><td>420</td><td>Italy</td><td>Caucasian</td><td>Population</td><td>PCR-RFLP</td><td>No CVD</td><td>LVM, IVS,LVEDD,</td></tr><tr><td>Heller,132004</td><td>113</td><td>Czech</td><td>Caucasian</td><td>based Hospital based</td><td>PCR-RFLP</td><td>Normotensive men</td><td>LVPWT LVM/LVMI, IVS,</td></tr><tr><td>Rao,27 2004</td><td>199</td><td>Republic China</td><td>Asian</td><td>Hospital based</td><td>PCR-RFLP</td><td>DCM and healthy</td><td>LVEDD, LVESD LVMI,IVS,LVEDD,</td></tr><tr><td>Stella,27 2004</td><td>210</td><td>Italy</td><td>Caucasian</td><td>Hospital based Taqman assay</td><td></td><td>EH</td><td>LVESD, LVPWT LVM, IVS, LVEDD,</td></tr><tr><td>Isaji,28 2005</td><td>221</td><td>Japan</td><td>Asian</td><td>Hospital based</td><td>PCR-RFLP</td><td>Normotensive and</td><td>LVESD, LVPWT LVM, IVS,LVEDD,</td></tr><tr><td>Safar,2005</td><td>426</td><td>France</td><td>Caucasian</td><td>Hospital based</td><td></td><td>EH EH</td><td>LVESD,LVPWT LVM</td></tr><tr><td>Chai,29 2006</td><td>79</td><td>Netherland</td><td>Caucasian</td><td>Hospital based PCR-RFLP</td><td></td><td>HCM</td><td>LVMI, IVS</td></tr><tr><td>Olcay,30 2006</td><td>85</td><td>Turkey</td><td>Caucasian</td><td>Hospital based</td><td>PCR-RFLP</td><td>EH and no CVD</td><td>LVMI, IVS, LVEDD,</td></tr><tr><td>Bauters,31 2007</td><td>213</td><td>France</td><td>Caucasian</td><td>Hospital based</td><td>PCR-RFLP</td><td>MI</td><td>LVESD,LVPWT LVEDV</td></tr><tr><td>Sun,' 2011</td><td>620</td><td>China</td><td>Asian</td><td>Hospital based</td><td>PCR-RFLP</td><td>EH with or without AF</td><td>LVM, IVS, LVEDD, LVPWT</td></tr><tr><td>Sia,34 2012</td><td>706</td><td>China</td><td>Asian</td><td>Hospital based</td><td>PCR-RFLP</td><td>EH and NM</td><td>LVM, LVEDD, LVESD</td></tr></table></body></html>",
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "The genotyping of CYP11B2 -344C/T polymorphism was mainly carried out across studies using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) followed by digestion with the restriction enzyme Hae III in 16 studies. One study was genotyped using allele-specific oligonucleotides.25 One study was genotyped by Taqman assay.27 Two studies did not mentionwhatmethodhadbeenused(Table1).However, the genotyping methods did not show any obvious confounding effect.In the eligible case-control studies,all the control populations obeyed HWE. ",
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "LVM/LVMI ",
        "text_level": 1,
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "There were 17 studies included in the present analysis of LVM/LVMI.A comparison of 5649 individuals who provided relevant data aboutLVM wasperformed(Table 2). Fifteen studies were evaluated (pe = 0.1288, Pheterogeneity < 0.01) for the differences in LVM between TT homozygotes and CC homozygotes (1337 vs 846). Seventeen studies $( p _ { \\mathrm { e } }$ $= 0 . 2 6 4 2$ Pheterogeneity $< 0 . 0 1$ ） were used to compare TT to $\\mathrm { T C + C C }$ (1976 vs 3673).There was no significant publication bias,but significant heterogeneity was detected among the reports.Then TT and $\\mathrm { C C / T C + C C }$ were compared across different ethnicities with respect to essential hypertension (EH) and normotension (NM). No statistically significant differenceswere detected when theLVM/LVMI of TT and $\\mathrm { C C / T C + C C }$ were compared,even in the EH and NM subgroups (see Figures 2 and 3). The comparison results were not significantly different under the allele model (C/T). ",
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "In order to confirm the source of heterogeneity, regression analyses of echocardiographic LVM/LVMI were performed.The contrast between TT and CC is shown in Table 3.Table 3 summarizes the results of regression according to single nucleotide polymorphism (SNP) $- 3 4 4 \\mathrm { C / T }$ ，ethnicity,country, design of included studies, number of included studies,age,sex,character of participants,prevalence of EH,year of publication,body mass index (BMI),systolic blood pressure (SBP),and diastolic blood pressure (DBP).The regression analyses showed the following: LVM/LVMI could be affected by the number of studies $( p = 0 . 0 4 )$ ， study design $( p = 0 . 0 6 )$ ,sex $( p = 0 . 0 9 )$ ）， and BP $( p _ { \\mathrm { S B P } } = 0 . 0 5$ $p _ { \\mathrm { D B P } } = 0 . 0 9 \\$ ).When the heterogeneity of any studies with respect to number of participants $n <$ 200,or $n > 2 0 0$ ,ethnicity,or EHand NM was close to zero (Figure 3).CC was associated with larger LVM values than TT $( p _ { \\mathrm { h e t e r o g e n e i t v } } = 0 . 5 3$ $I ^ { 2 } = 0 \\%$ $p _ { \\mathrm { v a l u e } } = 0 . 0 2$ ， $9 5 \\%$ CI $- 0 . 5 2 \\ ( - 0 . 9 7 , \\bar { - } 0 . 0 7 ) )$ in the $n < 2 0 0$ NM Caucasian subgroup (Kupari7,Delles8).No difference in LVM between TT and $\\mathrm { C C / T C + C C }$ was observed in any other subgroup. ",
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "For the sensitivity analyses, one study was omitted at a time and the pooled SD was recalculated.The mean difference of the remaining studies was also calculated.No study was found to move the point estimate outside the $9 5 \\%$ CI. ",
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "IVS ",
        "text_level": 1,
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "No significant publication bias was detected in the contrast of IVS with TT and $\\mathrm { C C / T C + C C }$ .There were13 eligible studies (2048 individuals) in the analysis of IVS and comparison of TT and CC.No significant difference was detected for the total group $( p = 0 . 0 8 )$ .The results were also not significant in the NM or EH subgroups ( $\\gamma _ { \\mathrm { N M } } =$ 0.87 and $p _ { \\mathrm { E H } } = 0 . 3 2 \\$ ).After adjustment for ethnicity as a covariate, the results became significant.When regression was performed forIVS under the homozygote comparison, age，sex,character,year of publication，SBP,and DBP were found to affect the results of the IVS comparison. There was no significant result under the allele model $( \\mathrm { C } / \\mathrm { T } )$ in IVS. ",
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "Sensitivity analyses for IVS showed that no single study could affect the results of the comparison between TT and CC or $\\mathrm { T C + C C }$ = ",
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "LVEDD ",
        "text_level": 1,
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "A total of 14 studies were available for comparison of TT and CC(1383 vs 857 individuals). There were 17 studies available for comparison of TT and $\\mathrm { T C } + \\mathrm { C C }$ (1738 vs 3401 individuals). There was obvious publication bias $( p _ { \\mathrm { e } }$ $= 0 . 0 3 1 2$ ）for LVEDD under the TT vs $\\mathrm { T C + C C }$ genetic model. Sensitivity analyses were performed and results showed that a part of one multi-center study could change the total LVEDD comparison results between TT and CC/ $\\mathrm { T C } { + } \\mathrm { C C } . ^ { 3 2 }$ The publication bias disappeared after this part of the study was removed (TT vs CC, $p _ { \\mathrm { e } } = 0 . 1 6$ ; TT vs $\\mathrm { T C + C C }$ ， $P _ { \\mathrm { ~ e ~ } } = 0 . 3 9$ ).The report in question showed this group of participants to be older (25-74 years old) and the age distribution to be more balanced within each decade group than in other studies.The LVEDD of the two parts showed obvious heterogeneity. The pooled LVEDD comparison is shown in Figure 4(TT vs CC, $9 5 \\%$ CI $- 0 . 6 0$ (-1.15, $- 0 . 0 6$ $p _ { \\mathrm { v a l u e } } = 0 . 0 3$ ; TT vs $\\mathrm { T C + C C }$ ， $9 5 \\%$ CI $- 0 . 1 7$ $( - 0 . 4 9 , 0 . 1 5 )$ $p _ { \\mathrm { v a l u e } } = 0 . 2 9 \\$ ). CC was found to have a larger LVEDD than TT. Covariate regression analyses showed that country, number, age,characteristics of participants, EH,and DBP could affect the LVEDD results in the homozygote comparison.When removing the major case of heterogeneity(Olcay3o) from the EH group,the results showed that CC had larger LVEDD values than TT $p _ { \\mathrm { h e t e r o } } .$ geneity $= 0 . 9 6$ $I ^ { 2 } = 0 \\%$ $9 5 \\%$ CI $- 0 . 8 6 ( - 1 . 1 4 , - 0 . 5 9 ) , p _ { \\mathrm { v a l u e } } <$ 0.0001).Under the $\\mathrm { C / T }$ allelic model,the C allele had largerLVEDD than the Tallele in the EH subset8,27 $( I ^ { 2 } = 0$ Pheterogeneity = 0.7,Pvalue <0.0001,95% CI-0.54 (-0.79, $- 0 . 3 0 ) )$ 1 ",
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "LVESD ",
        "text_level": 1,
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "Ten studies were included for comparison of TT vs CC (1121 vs 694 individuals). $P$ values were 0.50,0.65,and 0.004 for the total, NM,and EH groups,respectively. For comparison of TT vs $\\mathrm { T C + C C }$ ，12 studies were included (1196 vs 2232).Publication biaswas observed in the contrast of LVESD between TT and $\\mathrm { T C + C C }$ （204号 $( p _ { \\mathrm { e } } = 0 . 0 4 )$ ： ",
        "page_idx": 4
    },
    {
        "type": "table",
        "img_path": "images/416f8a49d8b45314f7c2a177ca7603117faf47d587c4c9074499749bb5c52980.jpg",
        "table_caption": [
            "Table 2. Pooled estimates of subgroup associations of LV structure and the CYPlIB2 -344C/T. "
        ],
        "table_footnote": [],
        "table_body": "<html><body><table><tr><td>Phenotype</td><td>Polymorphism</td><td>Outcome or subgroup</td><td>Studies</td><td>Participants</td><td>Effect estimate</td><td>Pheterogeneity</td><td>Pvalue Pe</td><td></td></tr><tr><td>LVM/LVMI</td><td>TT vs CC</td><td>All outcome</td><td>15</td><td>2183</td><td>00.20 (-0.46,00.85)</td><td><0.01</td><td>0.55</td><td>0.1288</td></tr><tr><td rowspan=\"12\"></td><td></td><td>Asian</td><td>2</td><td>244</td><td>0.20 (-0.29, 0.68)</td><td>0.1</td><td>0.43</td><td></td></tr><tr><td>Caucasian</td><td>12</td><td>1879</td><td></td><td>0.35 (-0.40, 1.11)</td><td><0.01</td><td>0.36</td><td></td></tr><tr><td>Others</td><td>一</td><td>60</td><td></td><td>一</td><td></td><td></td><td></td></tr><tr><td>EH outcome</td><td>6</td><td>418</td><td></td><td>0.65 (-0.36, 1.65)</td><td><0.01</td><td>0.21</td><td></td></tr><tr><td>Asian</td><td>一</td><td>113</td><td></td><td>1</td><td></td><td></td><td></td></tr><tr><td>Caucasian</td><td>5</td><td>305</td><td></td><td>0.71 [-0.57,1.99]</td><td><0.01</td><td>0.28</td><td></td></tr><tr><td>NM outcome</td><td>6</td><td>1259</td><td></td><td>0.11 (-1.07, 1.30)</td><td><0.01</td><td>0.85</td><td></td></tr><tr><td>Asian</td><td>一</td><td>78</td><td></td><td>1</td><td></td><td></td><td></td></tr><tr><td></td><td>Caucasian</td><td>6</td><td>1181</td><td>0.05 (-1.29, 1.39)</td><td><0.01</td><td>0.94</td><td></td></tr><tr><td>TT vs TC+CC</td><td>All outcome</td><td>17</td><td>5649</td><td>0.10 (-0.33,0.53)</td><td><0.01</td><td>0.64</td><td>0.2642</td></tr><tr><td></td><td>Asian</td><td>4</td><td>1746</td><td>-0.21 (-0.48, 0.07)</td><td><0.01</td><td>0.14</td><td></td></tr><tr><td></td><td>Caucasian</td><td>14</td><td>3766</td><td>0.25 (-0.36,0.85)</td><td><0.01</td><td></td><td>0.42</td></tr><tr><td>IVS TT vs CC</td><td>Others</td><td>一</td><td>137</td><td></td><td>1</td><td>一</td><td></td></tr><tr><td rowspan=\"14\"></td><td></td><td>EH outcome</td><td>1360</td><td></td><td>0.32 (-0.46,1.10)</td><td><0.01</td><td>0.42</td><td></td></tr><tr><td>Asian</td><td>7 2</td><td>735</td><td>-0.59 (-1.30, 0.1I)</td><td><0.01</td><td></td><td>0.1</td></tr><tr><td>Caucasian</td><td>5</td><td>625</td><td>0.64 (-0.41, 1.68)</td><td><0.01</td><td>0.23</td><td></td></tr><tr><td>NM outcome</td><td>7</td><td>2653</td><td>-0.09 (-0.95, 0.77)</td><td><0.01</td><td>0.83</td><td></td></tr><tr><td>Asian</td><td>2</td><td>302</td><td>-0.01 (-0.24,0.21)</td><td>0.94</td><td>0.92</td><td></td></tr><tr><td></td><td>5</td><td>2351</td><td>-0.12 (-1.21, 0.98)</td><td><0.01</td><td>0.83</td><td></td></tr><tr><td>Caucasian All outcome</td><td>13</td><td>2048</td><td>0.35 (-0.05, 0.74)</td><td><0.01</td><td>0.08</td><td>0.3810</td></tr><tr><td>Asian</td><td>2</td><td>244</td><td>0.43 (0.13, 0.72)</td><td>0.92</td><td>0.005</td><td></td></tr><tr><td>Caucasian</td><td>10</td><td>1744</td><td>0.36 (-0.13,0.85)</td><td><0.01</td><td>0.15</td><td></td></tr><tr><td rowspan=\"14\"></td><td>Others</td><td>一</td><td>60</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>EH outcome</td><td>4</td><td>283</td><td>0.90 (-0.87, 2.67)</td><td><0.01</td><td></td><td>0.32</td><td></td></tr><tr><td>Asian</td><td>一</td><td>113</td><td></td><td>一</td><td>一</td><td></td><td></td></tr><tr><td></td><td>Caucasian</td><td>3</td><td>170</td><td>1.06 (-1.63, 3.75)</td><td><0.01</td><td>0.44</td><td></td></tr><tr><td></td><td>NM outcome</td><td>6</td><td>1259</td><td>0.04 (-0.40, 0.47)</td><td><0.01</td><td>0.87</td><td></td></tr><tr><td></td><td>Asian</td><td></td><td>78</td><td></td><td>1</td><td>一</td><td></td></tr><tr><td></td><td>Caucasian</td><td>5</td><td>1181</td><td>-0.03 (-0.51, 0.45]</td><td><0.01</td><td>0.92</td><td></td></tr><tr><td>TT vs TC+CC</td><td>All outcome</td><td>15</td><td>4804</td><td>-0.02 (-0.44, 0.41)</td><td><0.01</td><td>0.94</td><td>0.1415</td></tr><tr><td></td><td>Asian</td><td>4</td><td>1176</td><td>-0.31 (-1.10,0.48)</td><td><0.01</td><td>0.44</td><td></td></tr><tr><td></td><td>Caucasian</td><td>10</td><td>3491</td><td>0.1l (-0.47, 0.69)</td><td><0.01</td><td>0.71</td><td></td></tr><tr><td rowspan=\"14\">LVEDD TT vs CC</td><td></td><td></td><td>137</td><td></td><td>一</td><td></td><td></td></tr><tr><td>Others EH outcome</td><td>一 4</td><td>571</td><td>-0.07 (-2.44, 2.30)</td><td><0.01</td><td>一 0.95</td><td></td></tr><tr><td>Asian</td><td>一</td><td>221</td><td></td><td></td><td></td><td></td></tr><tr><td>Caucasian</td><td>3</td><td>350</td><td>0.58 (-1.66, 2.82)</td><td>1 <0.01</td><td>一 0.61</td><td></td></tr><tr><td>NM outcome</td><td>6</td><td>2461</td><td>-0.10 (-0.76,0.57)</td><td><0.01</td><td>0.77</td><td></td></tr><tr><td>Asian</td><td>一</td><td>110</td><td></td><td>一</td><td></td><td></td></tr><tr><td>Caucasian</td><td>5</td><td>2351</td><td>-0.17 (-0.89, 0.54)</td><td><0.01</td><td>0.63</td><td></td></tr><tr><td>All outcome</td><td>14</td><td>2240</td><td>-0.34 (-1.26,0.58)</td><td><0.01</td><td>0.46</td><td>0.1627</td></tr><tr><td>Asian</td><td>3</td><td>354</td><td>-1.15 (-2.49, 0.19)</td><td><0.01</td><td>0.09</td><td></td></tr><tr><td>Caucasian</td><td>10</td><td>1826</td><td>-0.14 (-1.29, 1.01)</td><td><0.01</td><td></td><td>0.81</td></tr><tr><td></td><td>Others</td><td>60</td><td></td><td>1</td><td></td><td>1</td><td></td></tr><tr><td></td><td>EH outcome</td><td>一 4</td><td>283</td><td>-0.53 (-1.15,0.10)</td><td><0.01</td><td>0.10</td><td></td></tr><tr><td></td><td>Asian</td><td>一</td><td>113</td><td></td><td>一</td><td></td><td></td></tr><tr><td></td><td>Caucasian</td><td>3</td><td>170</td><td>-0.39 (-1.39, 0.61)</td><td><0.01</td><td>0.45</td><td></td></tr><tr><td rowspan=\"8\">TT vs TC+CC</td><td>NM outcome</td><td>6</td><td>1259</td><td>0.03 (-1.61, 1.67)</td><td><0.01</td><td>0.97</td><td></td></tr><tr><td>Asian Caucasian</td><td>一</td><td>78</td><td>0.09 (-1.73, 1.92)</td><td>1</td><td>一 0.92</td></table></body></html>",
        "page_idx": 5
    },
    {
        "type": "table",
        "img_path": "images/b160ab113a1f8a4fce4337564d840027ec705d445e8233f1eee8065e98f00c69.jpg",
        "table_caption": [
            "Table 2. (Continued) "
        ],
        "table_footnote": [
            "Effect estimate: pooled std. mean difference ( $9 5 \\%$ confidence interval); EH: essential hypertension; IVS: interventricular septal wallthickness; LVEDD: leftventriculadlameeEDfttricaytolamee;fttriclar;ftetriaae; LVPWT: left ventricular posterior wall thickness; NM: normotension; $\\mathfrak { p } _ { \\mathrm { e } } \\mathrm { : \\Omega }$ Egger's statisticforpublicationbias;Pheterogenetythe $Q$ statistic for heterogeneity; $\\boldsymbol { \\ p } _ { \\mathrm { v a l u e } }$ ：the statistical significance of the pooled estimate. "
        ],
        "table_body": "<html><body><table><tr><td rowspan=\"2\">Phenotype</td><td rowspan=\"2\">Polymorphism</td><td rowspan=\"2\">Outcome or subgroup</td><td rowspan=\"2\">Studies</td><td rowspan=\"2\">Participants</td><td rowspan=\"2\">Effect estimate</td><td rowspan=\"2\"> Pheterogeneity</td><td rowspan=\"2\">Pvalue</td><td rowspan=\"2\">pe</td></tr><tr><td></td></tr><tr><td></td><td></td><td>EH outcome</td><td>5</td><td>1085</td><td>-0.00 (-0.75,0.75)</td><td><0.01</td><td>1.00</td><td></td></tr><tr><td rowspan=\"12\">LVESD TT vs CC</td><td>Asian</td><td>2</td><td>735</td><td>0.19 (-0.60,0.98)</td><td></td><td>0.64</td><td></td></tr><tr><td>Caucasian</td><td>3</td><td>350</td><td>-1.34 (-1.66,-1.02)</td><td><0.01</td><td>0.89</td><td></td></tr><tr><td>NM outcome</td><td>7</td><td>2653</td><td>-0.03 (-0.85, 0.79)</td><td><0.01</td><td>0.95</td><td></td></tr><tr><td>Asian</td><td>2</td><td>302</td><td>0.04 (-0.18, 0.27)</td><td>0.47</td><td>0.7-</td><td></td></tr><tr><td>Caucasian</td><td>5</td><td>2351</td><td>-0.04 (-1.07, 0.98)</td><td><0.01</td><td>0.93</td><td></td></tr><tr><td>All outcome</td><td>10</td><td>1815</td><td>-0.37 (-1.46,0.71)</td><td><0.01</td><td>0.50</td><td>0.21</td></tr><tr><td>Asian</td><td>3</td><td>354</td><td>-1.14 (-2.41, 0.12)</td><td><0.01</td><td>0.08</td><td></td></tr><tr><td>Caucasian</td><td>7</td><td>1461</td><td>-0.04 (-1.40, 1.33)</td><td><0.01</td><td>0.96</td><td></td></tr><tr><td>EH outcome</td><td>4</td><td>283</td><td>-0.78 (-1.31,-0.24)</td><td><0.01</td><td>0.004</td><td></td></tr><tr><td>Asian</td><td>一</td><td>113</td><td></td><td></td><td>一</td><td></td></tr><tr><td>Caucasian</td><td>3</td><td>170</td><td>-0.74 (-1.59,0.12)</td><td><0.01</td><td>0.09</td><td></td></tr><tr><td></td><td>NM outcome</td><td>5</td><td>1062</td><td>0.40 (-1.32, 2.12)</td><td><0.01</td><td>0.65</td><td></td></tr><tr><td></td><td>Asian</td><td>一</td><td>78</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Caucasian</td><td>4</td><td>984</td><td>0.58 (-1.38,2.53)</td><td><0.01</td><td>0.56</td><td></td></tr><tr><td>TT vs TC+CC</td><td>All outcome</td><td>12</td><td>4134</td><td>-0.05 (-0.79, 0.68)</td><td><0.01</td><td>0.89</td><td>0.04 / 0.19</td></tr><tr><td></td><td>Asian</td><td>5</td><td>1463</td><td>-0.41 (-0.97, 0.15)</td><td><0.01</td><td>0.15</td><td></td></tr><tr><td></td><td>Caucasian</td><td>7</td><td>2671</td><td>0.23 (-0.91, 1.37)</td><td><0.01</td><td>0.69</td><td></td></tr><tr><td rowspan=\"10\">LVPWT TT vs CC</td><td>EH outcome</td><td>5</td><td>1085</td><td>-0.39 (-1.12, 0.35)</td><td><0.01</td><td>0.30</td><td></td></tr><tr><td>Asian</td><td>2</td><td>735</td><td>-0.10 (-0.25, 0.04)</td><td>0.38</td><td>0.17</td><td></td></tr><tr><td>Caucasian</td><td>3</td><td>350</td><td>-0.59 (-2.15, 0.97)</td><td><0.01</td><td>0.46</td><td></td></tr><tr><td>NM outcome</td><td>6</td><td>2017</td><td>0.34 (-0.96, 1.63)</td><td><0.01</td><td>0.61</td><td></td></tr><tr><td>Asian</td><td>2</td><td>302</td><td>-0.03 (-0.36,0.30)</td><td>0.16</td><td>0.86</td><td></td></tr><tr><td>Caucasian</td><td>4</td><td>1715</td><td>0.49 (-1.22, 2.21)</td><td><0.01</td><td>0.57</td><td>0.3282</td></tr><tr><td>All outcome</td><td>10</td><td>2218</td><td>0.45 (-0.13, 1.03)</td><td><0.01</td><td>0.13</td><td></td></tr><tr><td>Asian</td><td>2</td><td>244</td><td>0.43 (0.19, 0.79)</td><td>0.15</td><td>0.05</td><td></td></tr><tr><td>Caucasian</td><td>8</td><td>1974</td><td>0.48 (-0.23, 1.19)</td><td><0.01</td><td>0.81</td><td></td></tr><tr><td>EH outcome</td><td>4</td><td>283</td><td>1.53 (-0.09, 3.15)</td><td><0.01</td><td>0.06</td><td></td></tr><tr><td rowspan=\"10\">TT vs TC+CC</td><td>Asian</td><td>一</td><td>113</td><td></td><td></td><td></td><td></td></tr><tr><td>Caucasian</td><td>3</td><td>170</td><td>1.80 (-0.51, 4.11)</td><td><0.01</td><td>0.13</td><td></td></tr><tr><td>NM outcome</td><td>5</td><td>1208</td><td>0.0l (-0.86,0.88)</td><td><0.01</td><td>0.98</td><td></td></tr><tr><td>Asian</td><td>一</td><td>78</td><td></td><td></td><td></td><td></td></tr><tr><td>Caucasian</td><td>4</td><td>1130</td><td>-0.05 (-1.05,0.95)</td><td><0.01</td><td>0.92</td><td></td></tr><tr><td>All outcome</td><td>12</td><td>4475</td><td>0.16 (-0.32,0.64)</td><td><0.01</td><td>0.51</td><td>0.8557</td></tr><tr><td>Asian</td><td>4</td><td>1176</td><td>-0.54 (-1.56, 0.49)</td><td><0.01</td><td>0.30</td><td></td></tr><tr><td>Caucasian</td><td>8</td><td>3299</td><td>0.48 (-0.10, 1.06)</td><td><0.01</td><td>0.11</td><td></td></tr><tr><td>EH outcome</td><td>5</td><td>652</td><td>0.51 (-2.09, 3.12)</td><td><0.01</td><td>0.70</td><td></td></tr><tr><td>Asian</td><td></td><td>221</td><td></td><td></td><td></td><td></td></tr><tr><td>Caucasian</td><td></td><td>4</td><td>434</td><td>1.39 (-0.77, 3.56)</td><td><0.01</td><td>0.21</td><td></td></tr><tr><td></td><td>NM outcome</td><td>5</td><td>2348</td><td>-0.07 (-0.46,0.33)</td><td><0.01</td><td>0.74</td><td></td></tr><tr><td></td><td>Asian</td><td></td><td>110</td><td></td><td></td><td>一</td><td></td></tr><tr><td>Caucasian</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td>4</td><td>2238</td><td>-0.12 (-0.56, 0.31)</td><td><0.01</td><td>0.58</td><td></td></tr></table></body></html>",
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "Results of sensitivity analyses for LVESD under the homozygote comparison and the dominant genetic model showed that Schunkert,1999-3 could change the overall results ofLVESD comparison.3² If Schunkert,1999-3 was omitted, then the publication bias disappeared(TT vs CC, $p _ { \\mathrm { e } } = 0 . 8 6$ TT vs $\\mathrm { T C + C C }$ $p _ { \\mathrm { e } } = 0 . 1 9 \\$ ，and CC had larger LVESD values than TT $( p _ { \\mathrm { h e t e r o g e n e i t y } } < 0 . 0 1$ $p _ { \\mathrm { v a l u e } } = 0 . 0 0 2$ $9 5 \\%$ CI $- 0 . 7 1$ (-1.16, $- 0 . 2 6 )$ ).No differences inLVESD were found during a comparison of other groups under the dominant genetic model and the homozygote comparison. ",
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "TT CC Std. Mean Difference Std.Mean Difference Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl IV, Random, 95% Cl 5.2.1 EH-TTvsCC Delles C,2001-EH 272 57 15 260 53 11 6.5% 0.21 [-0.57, 0.99] Isaji M,2005 199 6 83 197 9 30 6.8% 0.29 [-0.13, 0.71] Kurland L,2002-A 140 28 17 135 27 8 6.4% 0.17 [-0.67, 1.02] Kurland L,2002- 148 33 16 131 16 8 $6 . 4 \\%$ （204号 0.57[-0.30, 1.44] Olcay A,2006 155 14 11 160.7 15 20 $6 . 5 \\%$ （204号 -0.38 [-1.12,0.36] Safar ME,2005 59.2 13.2 48 58.9 15.1 38 $6 . 8 \\%$ （ 0.02[-0.40,0.45] Stella P,2004 193 6.9 65 168 6.9 48 $6 . 7 \\%$ （ 3.60 [2.99, 4.20] Subtotal $( 9 5 \\%$ Cl) 255 163 （20 $4 6 . 0 \\%$ （204号 0.65[-0.36, 1.65] Heterogeneity: $\\mathsf { T a u } ^ { 2 } = 1 . 7 1$ $\\mathsf { C h i } ^ { 2 } = 1 1 1 . 9 2$ ，df $\\dot { \\mathbf { \\eta } } = 6$ $\\mathsf { P } < 0 . 0 0 0 0 1$ ） $1 ^ { 2 } = 9 5 \\%$ Test for overal effect: $Z = 1 . 2 6$ $\\mathsf { P } = 0 . 2 1$ ） 5.2.2 NM-TTvsCC Delles C,2001-NM 214 35 20 228 39 18 $6 . 6 \\%$ （ -0.37 [-1.01,0.27] Heller S,2004 92 15 26 84 16 25 $6 . 7 \\%$ （ 0.51[-0.05, 1.07] Kupari M,1998 149 39 22 182 58 20 $6 . 6 \\%$ （ -0.66 [-1.28,-0.04] Rao L,2004-NM 61 5 52 58 7 26 $6 . 8 \\%$ （ 0.52 [0.04, 1.00] Sarzani R, $2 0 0 3 +$ 77.6 1.7 65 82.5 2.3 34 $6 . 7 \\%$ （ -2.53[-3.07,-1.98] Sarzani R,2003-M 93.7 2.5 61 93.5 3.2 37 $6 . 8 \\%$ （ 0.07 [-0.34,0.48] Schunkert H,1999-1 98.5 3.3 144 96.7 3 75 （204号 $6 . 9 \\%$ （ 0.56 [0.28,0.84] Schunkert H,1999-3 94.7 1.5 362 90.5 1.6 272 $6 . 9 \\%$ （204号 2.72 [2.50,2.93] Subtotal $( 9 5 \\%$ Cl) 752 507 （204号 $5 4 . 0 \\%$ （20 0.11 [-1.07, 1.30] Heterogeneity: $\\mathsf { T a u } ^ { 2 } = 2 . 8 6$ $\\mathsf { C h i } ^ { 2 } = 4 7 8 . 7 9$ ，df ${ \\dot { \\mathbf { \\sigma } } } = 7 \\mathbf { \\sigma }$ $\\mathsf { P } < 0 . 0 0 0 0 1$ ） $1 ^ { 2 } = 9 9 \\%$ （20 Test for overall effect: $Z = 0 . 1 9$ $( \\mathsf { P } = 0 . 8 5$ ） Total $( 9 5 \\%$ Cl) 1007 670 $1 0 0 . 0 \\%$ （204号 0.36 [-0.43, 1.15] Heterogeneity: $\\mathsf { T a u } ^ { 2 } = 2 . 3 4$ $\\mathsf { C h i } ^ { 2 } = 6 0 1 . 4 7$ ，df $= 1 4$ 1 $\\mathsf { P } < 0 . 0 0 0 0 1$ ） $1 ^ { 2 } = 9 8 \\%$ （204 -10 -5 0 5 10 Test for overall effect: $Z = 0 . 8 9$ 1 $\\mathsf { P } = 0 . 3 7 \\$ Test for subgroup differences: $\\mathsf { C h i } ^ { 2 } = 0 . 4 6$ df $= 1$ $( \\mathsf { P } = 0 . 5 0 )$ $1 ^ { 2 } = 0 \\%$ （20 ",
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "After covariate regression for LVESD under the homozygote comparison,number of participants,age, sex,characteristics,yearof publication,SBP,andDBPwereall found to affect the results of the LVESD comparison.In the $n >$ $2 0 0 \\mathrm { E H }$ subgroup (Isaji,28 Stella²7), CC had larger LVESD than TT $( p _ { \\mathrm { h e t e r o g e n e i t y } } = 0 . 1 5$ $p _ { \\mathrm { v a l u e } } < 0 . 0 0 0 1$ ， $9 5 \\%$ CI -1.02 $( - 1 . 4 5 , - 0 . 6 0 ) \\$ ).Underthe $\\mathrm { C / T }$ allelic model, the C allele hadlargerLVESD values than the $\\mathrm { \\Delta T }$ allele in the EH sub$\\mathrm { s e t } ^ { 8 , 2 7 }$ $( I ^ { 2 } = 0$ $p _ { \\mathrm { h e t e r o g e n e i t y } } = 0 . 3 9$ $p _ { \\mathrm { v a l u e } } < 0 . 0 0 0 1$ ， $9 5 \\%$ CI $- 0 . 7 2 \\ : ( - 0 . 9 7 , - 0 . 4 7 ) )$ ",
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "LVPWT ",
        "text_level": 1,
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "There were 1O studies included for the LVPWT and a total of1484 TTs vs 734 CCs. $P$ values of 0.13,0.98,and 0.06 were recorded for the total,NM,and EH groups, respectively.As forcomparison of TT vs $\\mathrm { ( T C + C C ) }$ ，12 studies were included (1524 vs 2951). $P$ values of 0.51, 0.74,and O.21 were recorded for the three groups.Under the homozygote comparison, covariate regression results demonstrated that ethnicity,country,design,number of participants，age，sex，and participant characteristics could affect the results of the LVPWT comparison.In the $n < 2 0 0$ EH subgroup,TT was associated with larger LVPWT values than CC $( p _ { \\mathrm { h e t e r o g e n e i t y } } = 0 . 7 4$ $p _ { \\mathrm { v a l u e } } = 0 . 0 2$ ， $9 5 \\%$ CI 0.67 (0.12, 1.22)).8,30 ",
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "Discussion ",
        "text_level": 1,
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "Thisisa systematic reviewof the literature in the formof an update meta-analysis of the association between the CYP11B2 -344C/T polymorphism (rs1799998) and left ventricular structure.In total,2O studies and 678O subjects were analyzed for left ventricular parameters.The main finding of the present meta-analysis was that echocardiographic left ventricular diameters (LVEDD and LVESD）were greater in CC than in TT on average (involving 17 studies). CC individuals had larger LVM/ LVMI ratios than TT individuals in the subgroup of NM Caucasians $( n < 2 0 0 )$ .AmongAsians,TThadlargerIVS than CC,and TThadlargerLVPWT than CC in the much smaller sample $( n < 2 0 0 )$ )EH subgroup without heterogeneity $( p _ { \\mathrm { h e t e r o g e n e i t y } } > 0 . 0 5$ ， $p _ { \\mathrm { v a l u e } } < 0 . 0 1$ ,respectively). There was no obvious heterogeneity among the subgroups.The same allele (e.g. the C allele) of rsl799998 was found to have different effects in different populations.No publication bias was detected in any these results.The same results showed CC to be associated with largerleft ventricle diameter than TT in the non-heterogeneity subgroup analyses. Statistical differences were observed among continuous echocardiographic variables only during comparisons of homozygotes. ",
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "In 2008，Sookoian et al. reported that the CYP11B2 -344T allele was associated with an increased thickness of ",
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "a. TT CC Std. Mean Difference Std. Mean Difference Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random,95% Cl IV, Random,95% Cl n<200 --EH, Delles C,2001-EH 27257 15 26053 11 10.9% 0.21 [-0.57, 0.99] Kurland L,2002-A 140 28 17 13527 8 10.1% 0.17 [-0.67, 1.02] Kurland L,2002- 148 33 16 131 16 8 9.7% 0.57[-0.30, 1.44] Olcay A,2006 15514 11 160.715 20 （204号 $1 1 . 5 \\%$ （204 -0.38 [-1.12, 0.36] Subtotal $( 9 5 \\%$ Cl) 59 47 $4 2 . 2 \\%$ （204号 0.11 [-0.29, 0.51] Heterogeneity:Tau $\\overset { ? } { = } 0 . 0 0$ $C \\mathsf { h } \\mathsf { i } ^ { 2 } = 2 . 8 4$ ${ \\mathsf { d f } } = 3 ( { \\mathsf { P } } = 0 . 4 2 )$ $1 ^ { 2 } = 0 \\%$ （204号 Test for overall effect: $z = 0 . 5 2$ （204号 $( \\mathsf { P } = 0 . 6 0 )$ :n<200--NM Delles C,2001-NM 21435 20 22839 18 13.2% -0.37 [-1.01, 0.27] Heller S, 2004 9215 26 8416 25 14.7% 0.51 [-0.05, 1.07] Kupari M,1998 14939 22 18258 20 13.5% -0.66 [-1.28,-0.04] Rao L,2004-NM 61 5 52 58 7 26 16.4% 0.52 [0.04, 1.00] Subtotal $( 9 5 \\% 0 \\% )$ （20 120 89 57.8% 0.02 [-0.57, 0.61] Heterogeneity: $\\mathsf { T a u } ^ { 2 } = 0 . 2 8$ $C h ^ { \\prime 2 } = 1 2 . 7 8$ ,df =3(P= 0.005); $1 ^ { 2 } = 7 7 \\%$ （204 Testfor overall efect: $Z = 0 . 0 7 ( \\mathsf { P } = 0 . 9 4 )$ （20 Total $( 9 5 \\%$ CI) 179 136100.0% 0.07 [-0.28, 0.43] Heterogeneity: $\\mathsf { T a u } ^ { 2 } = 0 . 1 4$ $C h ^ { \\prime 2 } = 1 5 . 6 2$ ${ \\mathsf { d } } { \\mathsf { f } } = 7 \\ ( { \\mathsf { P } } = 0 . 0 3 )$ $1 ^ { 2 } = 5 5 \\%$ （20 -2 -1 0 1 2 Test foroverall ffect: $Z = 0 . 4 1 \\ ( { \\mathsf P } = 0 . 6 8 )$ Test for subgroup differences: $\\mathsf { C h i } ^ { 2 } = 0 . 0 5$ $\\mathsf { d f } = 1 \\ ( \\mathsf { P } = 0 . 8 2 ) , \\mathsf { I } ^ { 2 } = 0 \\%$   \nb. T Cc Std. Mean Difference Std.Mean Difference Study orSubqroupMean SD Total Mean SD Total WeiqhtIV.Random.95%Cl IV.Randqm.95% Cl n<200-NM--Caucasian Delles C,2001-NM 21435 20 22839 1848.5% -0.37 [-1.01, 0.27] KupariM,1998 14939 22 18258 2051.5% -0.66 [-1.28,-0.04] Subtotal (95% Cl) 42 38100.0% -0.52 [-0.97, -0.07] Heterogeneity. Tau ${ \\bf \\varepsilon } = 0 . 0 0$ Chi²=0.40,df=1(P =0.53);F=0% Test foroveralleffect:Z =2.28 $( P = 0 . 0 2 )$ -2 -1 0 1 2 ",
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "the posterior wall of the left ventricle.14 Other studies have shown the $- 3 4 4 \\mathrm { T }$ allele to be associated with greater IVS and PWT values.The previous version of the present metaanalysis contained14 studies and more than 4ooo individuals.The main limit of that study was that it did not contain any Chinese or other Asian individuals,with the exception of one study that was performed on Japanese participants. The present meta-analysis was consistent with a 2008 reportby Sookoian etal.among small subgroups $( n < 2 0 0 )$ but this relationship was not detected when the groups were pooled. One of the reasons for this may be that the more groups pooled, the more confounding factors there were. Most of those confounding factors were not recorded, so the association results may be different or biased. ",
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Because of the heterogeneity present, sensitivity analyses and covariance regression analyses were performed to identify the main factors capable of affecting the results. Ethnicity, sample size,age, sex, participant characteristics, study design,DBP, and SBP could all influence the results. Patients were regrouped according to ethnicity， sample size,and othercharacteristics.CCwas still associated with larger LVEDD and LVESD values in the subsets with $p _ { \\mathrm { h e t e r o g e n e i t y } } > 0 . 0 5$ $p _ { \\mathrm { v a l u e } } < 0 . 0 5$ during the comparison of homozygotes. These results suggested that the CC genotype of rs1799998 might be associated with larger left ven triculardiameter. ",
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Aldosterone independently influences the vascular environment in humans.It does so by affecting structural and functional modification of the arterial wall as derived from mineralocorticoid receptors.35 Aldosterone has endocrine properties.These properties may contribute to the patho physiology of cardiac fibrosis, cardiovascular dysfunction, p. TT TC+CC Std. Mean Difference Std. Mean Difference Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random,95% Cl IV, Random, 95% Cl Bauters C,2007 55.5 14.6 64 56.9 14.9 149 4.9% -0.09[-0.39,0.20] Delles C,2001-EH 50.3 4 15 51.7 3.2 40 4.3% -0.40 [-1.00,0.20] Delles C,2001-NM 50.6 3.6 20 51.6 3.4 45 4.5% -0.29[-0.81,0.24] Heller S,2004 54.3 3.9 26 53.7 4.2 87 4.7% 0.14 [-0.29, 0.58] Hengstenberg C,2000 55.7 0.6 187 55.1 0.5 419 5.0% 1.12 [0.94, 1.31] Isaji M, 2005 49 0.5 83 48.7 0.5 138 4.9% 0.60 [0.32, 0.88] Kupari M, 1998 47.1 2.9 22 50.4 4.1 62 4.5% -0.85[-1.36,-0.35] Olcay A,2006 28.9 1.2 11 27.5 0.9 74 （204号 $4 . 2 \\%$ （204号 1.47 [0.80, 2.15] Ortlepp JR,2001 47.4 7.8 35 46.9 6.2 70 4.7% 0.07[-0.33, 0.48] Patel R,2000 44.2 6.4 37 42 5.6 100 $4 . 8 \\%$ （204号 0.38[-0.00, 0.76] Rao L,2004-DCM 67.4 7 47 66.9 7.3 42 4.7% 0.07[-0.35,0.49] Rao L,2004-NM 46 4 52 46.3 5 58 （204号 $4 . 8 \\%$ （ -0.07 [-0.44, 0.31] Sarzani R,2003F 46.3 0.4 65 46.6 0.4 137 （204号 $4 . 9 \\%$ （204号 -0.75[-1.05,-0.44] Sarzani R,2003-M 51.5 0.5 61 51.8 0.5 157 $4 . 9 \\%$ （204号 -0.60[-0.90,-0.30] Schunkert H,1999-1 48.5 0.4 144 48.5 0.4 291 （204号 $5 . 0 \\%$ （ 0.00 [-0.20,0.20] Sia SK,2012-EH 49.21906716 6.19422269 268 50.39739837 4.99371634 246 $5 . 0 \\%$ （204号 -0.21[-0.38,-0.03] Sia SK,2012-NM 49.99384615 6.32947883 9149.37891089 5.20901588 101 $4 . 9 \\%$ （ 0.11[-0.18, 0.39] Stella P,2004 48.5 0.6 65 49.4 0.7 145 $4 . 9 \\%$ （204 -1.34 [-1.66,-1.02] Sun X,2011 47 4.3 280 47.2 4.6 340 （204号 $5 . 0 \\%$ （204号 -0.04 [-0.20, 0.11] Takai E,2002 132.1 3.9 87 146 6.1 114 $4 . 8 \\%$ （204号 -2.63[-3.01,-2.25] Tamaki S,1999 3.02 0.3 75 3.1 0.3 61 $4 . 8 \\%$ -0.27[-0.60,0.07] Total $( 9 5 \\% 0 \\% )$ （20 1735 2876 $1 0 0 . 0 \\%$ -0.17 [-0.49, 0.15] Heterogeneity: $\\mathsf { T a u } ^ { 2 } = 0 . 5 2$ Chi $= 4 9 3 . 1 9$ df $= 2 0$ (P <0.00001); $1 ^ { 2 } = 9 6 \\%$ -4 + -2 0 2 4 Test for overall effect: $Z = 1 . 0 6$ （204号 $( { \\mathsf { P } } = 0 . 2 9 )$ （204号 Favours experimentalFavours control ",
        "page_idx": 8
    },
    {
        "type": "table",
        "img_path": "images/ac18727892cac1491a28c2efb569a1b954f66811204b76dffa5547d029060286.jpg",
        "table_caption": [
            "reeeeee "
        ],
        "table_footnote": [
            ""
        ],
        "table_body": "<html><body><table><tr><td></td><td colspan=\"2\">LVM/LVMI</td><td colspan=\"2\">LVEDD</td><td colspan=\"2\">LVESD</td><td colspan=\"2\">IVS</td><td colspan=\"2\">LVPWT</td></tr><tr><td></td><td>Estimate 95% Cl</td><td>P</td><td>Estimate 95% Cl</td><td>p</td><td>Estimate 95% Cl</td><td>p</td><td>Estimate 95% Cl</td><td>p</td><td>Estimate 95% Cl</td><td>P</td></tr><tr><td>-344C/T</td><td>-5.22 (-9.12,-1.11)</td><td>0.013</td><td>-4.06 (-7.02, -1.11)</td><td>0.007</td><td>6.82 (2.13, 1.50)</td><td>0.004</td><td>-5.05 (-8.36,-1.74)</td><td>0.003</td><td>1.81 (-3.6,7.3)</td><td>0.51</td></tr><tr><td>Number</td><td>0.003 (0.0,0.006)</td><td>0.04</td><td>0.005 (0.0028,0.0078)</td><td><0.001</td><td>0.003 (0.0023,0.0038)</td><td><0.001</td><td>-0.0019 (-0.0043,0.0006)</td><td>0.1413</td><td>0.002 (0.0012,0.004)</td><td><0.001</td></tr><tr><td>Age</td><td>-0.037 (-0.14,0.07)</td><td>0.48</td><td>0.1l (0.036,0.19)</td><td>0.004</td><td>-0.074 (-0.11,-0.04)</td><td><0.001</td><td>-0.1226 (-0.21,-0.0354)</td><td>0.0059</td><td>-0.04 (-0.094, 0.006)</td><td>0.082</td></tr><tr><td>Sex</td><td>2.31 (-0.38,4.99)</td><td>0.09</td><td>0.60 (-1.01,2.22)</td><td>0.46</td><td>-2.79 (-4.16, -1.41)</td><td><0.001</td><td>2.1288 (0.4388, 3.8189]</td><td>0.0136</td><td>1.51 (0.53, 2.48)</td><td>0.003</td></tr><tr><td>Character</td><td>-0.024 (-0.56,0.51)</td><td>0.93</td><td>0.59 (0.35, 0.84)</td><td><0.001</td><td>-0.16 (0.035,0.29)</td><td>0.013</td><td>-0.3644 (-0.70,0.028)</td><td>0.0336</td><td>-0.20 (-0.43,0.024)</td><td>0.08</td></tr><tr><td>DBP</td><td>-0.072 (-0.15,0.01)</td><td>0.09</td><td>0.59 (0.35, 0.84)</td><td><0.001</td><td>-0.24 (-0.37,-0.12)</td><td><0.001</td><td>-0.0917 (-0.1541,0.0294)</td><td>0.0039</td><td>-0.047 (-0.28,0.19)</td><td>0.7</td></tr><tr><td>SBP</td><td>0.046 (0.00,0.092)</td><td>0.05</td><td>0.00Il (-0.051,0.053)</td><td>0.97</td><td>0.15 (0.067, 0.22)</td><td><0.001</td><td>-0.0000 (-0.0331,0.0331)</td><td>0.9986</td><td>0.048 (-0.10,0.20)</td><td>0.54</td></tr><tr><td>Year</td><td>-0.39 (-0.99, 0.21)</td><td>0.20</td><td>0.53 (-0.28, 1.33)</td><td>0.20</td><td>0.38 (0.21, 0.55)</td><td><0.001</td><td>-1.323 (-2.3187,-0.3273)</td><td>0.0092</td><td>-0.10 (-0.38, 0.17)</td><td>0.46</td></tr><tr><td>Ethnicity</td><td>0.80 (-2.1,3.67)</td><td>0.59</td><td>3.74 (-0.70, 8.19)</td><td>0.10</td><td>0.84 (-0.17, 1.85)</td><td>0.10</td><td>-4.2572 (-7.9872,-0.5271)</td><td>0.0253</td><td>2.48 (1.16, 3.82)</td><td><0.001</td></tr><tr><td>Design</td><td>-2.98 (-6.02, 0.062)</td><td>0.06</td><td>-1.14 (-3.32, 1.03)</td><td>0.30</td><td>0.87 (-0.30,2.04)</td><td>0.15</td><td>-1.3605 (-4.2203,1.4993)</td><td>0.3511</td><td>-3.95 (-6.01,-1.90)</td><td><0.001</td></tr><tr><td>Country</td><td>0.04 (-0.26,0.34)</td><td>0.79</td><td>-0.33 (-0.67,0.0081)</td><td>0.06</td><td>-0.07 (-0.21,0.074)</td><td>0.35</td><td>-0.0375 (-0.4534,0.3785)</td><td>0.8599</td><td>0.22 (0.0029, 0.43)</td><td>0.05</td></tr><tr><td>EH</td><td>0.43 (-1.88, 2.74)</td><td>0.72</td><td>1.35 (-0.13, 2.82)</td><td>0.07</td><td>-0.26 (-1.18,0.65)</td><td>0.57</td><td>60.7614(-65.62, 187.14)</td><td>0.346</td><td>-0.26 (-2.48, 1.96)</td><td>0.82</td></tr><tr><td>BMI</td><td>-0.072 (-0.22,0.076)</td><td>0.34</td><td>-0.085 (-0.20,0.025)</td><td>0.13</td><td>0.06 (0.015,0.113)</td><td>0.1</td><td>0.0382 (-0.0465,0.1228)</td><td>0.377</td><td>-0.04 (-0.089,0.009)</td><td>0.1</td></tr></table></body></html>",
        "page_idx": 9
    },
    {
        "type": "table",
        "img_path": "images/a6a409ac11b1d4d16e7f0008d10fd2ee58d7e9acf05dc605fdf7768ecfc2b1fe.jpg",
        "table_caption": [],
        "table_footnote": [],
        "table_body": "<html><body><table><tr><td>a.</td><td colspan=\"3\">TT</td><td colspan=\"3\">CC</td><td colspan=\"2\">Std. Mean Difference</td><td colspan=\"2\">Std.Mean Difference</td></tr><tr><td>Study or Subgroup</td><td>Mean</td><td>SD</td><td></td><td>TotalMean</td><td>SD</td><td></td><td>Total Weight</td><td>IV, Random, 95% Cl</td><td>IV, Random,95% Cl</td><td></td></tr><tr><td>Bauters C,2007</td><td>55.5</td><td></td><td>64</td><td>55.1</td><td>14.9</td><td>52</td><td>6.1%</td><td>0.03 [-0.34,0.39]</td><td></td><td></td></tr><tr><td>Delles C,2001-EH</td><td>50.3</td><td>14 4</td><td>15</td><td>53.7</td><td>2.3</td><td>11</td><td>5.5%</td><td>-0.97 [-1.80,-0.14]</td><td></td><td></td></tr><tr><td>Delles C,2001-NM</td><td>50.63.6</td><td></td><td>20</td><td>51.5</td><td>3.2</td><td>18</td><td>5.8%</td><td>-0.26[-0.90,0.38]</td><td></td><td></td></tr><tr><td>Heller S,2004</td><td>54.3 3.9</td><td></td><td>26</td><td>53.6</td><td>3.5</td><td>25</td><td>5.9%</td><td>0.19 [-0.36,0.74]</td><td></td><td></td></tr><tr><td>Hengstenberg C,2000</td><td>55.70.6</td><td></td><td>187</td><td>56.7</td><td>0.7</td><td>120</td><td>6.2%</td><td>-1.56 [-1.82,-1.30]</td><td></td><td></td></tr><tr><td>Isaji M, 2005</td><td>490.5</td><td></td><td>83</td><td>49.5</td><td>0.8</td><td>30</td><td>6.0%</td><td>-0.84 [-1.27, -0.41]</td><td></td><td></td></tr><tr><td>Kupari M,1998</td><td>47.1 2.9</td><td></td><td>22</td><td>51.2</td><td>4.1</td><td>20</td><td>5.7%</td><td>-1.14[-1.80,-0.48]</td><td></td><td></td></tr><tr><td>Olcay A,2006</td><td>28.9</td><td>1.2</td><td>11</td><td>27.9</td><td>1.4</td><td>20</td><td>5.6%</td><td>0.73[-0.03, 1.49]</td><td></td><td></td></tr><tr><td>Ortlepp JR,2001</td><td>47.77.8</td><td></td><td>35</td><td>46.7</td><td>4.9</td><td>17</td><td>5.9%</td><td>0.14 [-0.44, 0.72]</td><td></td><td></td></tr><tr><td>Patel R,2000</td><td>44.2 6.4</td><td></td><td>37</td><td>42.9</td><td>5</td><td>23</td><td>5.9%</td><td>0.22 [-0.30,0.74]</td><td></td><td></td></tr><tr><td>Rao L,2004-DCM</td><td>67.4</td><td>11</td><td>47</td><td>66.1</td><td>9.7</td><td>6</td><td>5.4%</td><td>0.12 [-0.73,0.97]</td><td></td><td></td></tr><tr><td>Rao L,2004-NM</td><td>46</td><td>4</td><td>52</td><td>48</td><td>6</td><td>26</td><td>6.0%</td><td>-0.42[-0.89,0.06]</td><td></td><td></td></tr><tr><td>Sarzani R,2003F</td><td>46.3 0.4</td><td></td><td>65</td><td>47.4</td><td>0.5</td><td>34</td><td>5.9%</td><td>-2.50 [-3.05,-1.95]</td><td></td><td></td></tr><tr><td>Sarzani R,2003-M</td><td>51.50.5</td><td></td><td>61</td><td>52</td><td>0.7</td><td>37</td><td>6.0%</td><td>-0.85[-1.28,-0.42]</td><td></td><td></td></tr><tr><td>SchunkertH,1999-1</td><td>48.50.4</td><td></td><td>144</td><td>48</td><td>0.5</td><td>75</td><td>6.2%</td><td>1.14 [0.84, 1.44]</td><td></td><td></td></tr><tr><td>Stella P,2004</td><td>48.50.6</td><td></td><td>65</td><td>49.1</td><td>0.8</td><td>48</td><td>6.1%</td><td>-0.86[-1.25, -0.47]</td><td></td><td></td></tr><tr><td>Takai E,2002</td><td>132.1 3.9</td><td></td><td>87</td><td>146</td><td>4.4</td><td>23</td><td>5.8%</td><td>-3.44 [-4.10, -2.79]</td><td></td><td></td></tr><tr><td colspan=\"7\">Total (95% CI) 1021</td><td>-0.60 [-1.15,-0.06]</td><td></td><td></td><td></td></tr><tr><td colspan=\"7\">Heterogeneity: Tau²= 1.23; Chi²= 359.19,df=16 (P<0.00001);|²= 96%</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan=\"8\">Test for overall effect: Z= 2.18 (P = 0.03) Favoursexperimental</td><td>-4</td><td>-2 0</td><td>2</td><td>4</td></tr></table></body></html>",
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "and progressive renal dysfunction.36-38 Recent evidence has shown that aldosterone may play an important role in potentiating some of the hypertrophic effects of angiotensin Ion culturedvascular smooth muscle(VSM) cells.Those cells showed evidence of mRNA for CYP11B2.36-38 ",
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Aldosterone increases the synthesis of collagen Iat the mRNA and protein level.39 And aldosterone receptor blockade using spironolactone markedly reduces procollagen type III amino-terminal peptide.All these results suggest that aldosterone is a key point of collagen turnover.39 Some investigations have shown the expression of CYP11B2 mRNAand production of aldosterone in the vessel wall and vascular VSM cells.40.41 In 1992, Lifton et al. demonstrated that mutations in the aldosterone synthase gene could account for all the physiological abnormalities associated with glucocorticoid-remediable aldosteronism and that this mutation could cause hypertension in otherwise phenotypically normal animals or humans.42 The polymorphism $- 3 4 4 \\mathrm { C / T }$ is located upstream of the start of translation within a binding site for the transcription factor, steroidogenic factor-1 (SF-1). SF-1 is necessary for the development of adrenal glands and other steroidogenic tissues and for expression of most of the enzymes involved in adrenal steroid biosynthesis;7-344C/Tis located in the promoter of the CYP11B2 gene and might influence the gene expression byaffecting the binding of the SF-1 transcription factor.A previous study showed that the $- 3 4 4 \\mathrm { C }$ allele binds to the SF-1 binding site more strongly than the T allele does in vitro.43 Several studies have shown that BP is higher in CC andTCthan in TT individuals.Some studies have also shown the $- 3 4 4 \\mathrm { C }$ alleleto beassociatedwith increasedleft ventricular size and decreased baroreflex sensitivity in healthy people.44 This supports the results of the present meta-analysis with respect to the NM Caucasian subgroup with $n < 2 0 0$ (CC had larger LVM/LVMIthan TT,Petrogene $_ { \\mathrm { i t y } } = 0 . 5 3$ $I ^ { 2 } = 0 \\%$ $p _ { \\mathrm { v a l u e } } = 0 . 0 2 \\$ ： ",
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "Kupair et al. observed that LVM increased with the number of copies of $- 3 4 4 \\mathrm { C }$ in young adults.7 Delles et al. also found that CCs had greater LVEDD than those with the TTs in arterial hypertension, suggesting that CC genotype might be associated with early LVH.& A recent, large, genome-wide association study ofBP traits also supported the association between BP traits and CYP11B2 $- 3 4 4 \\mathrm { C } /$ T.45 Those results showed that the $- 3 4 4 \\mathrm { C }$ allele may be more strongly associated with large left ventricular size. ",
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "In the present study, differences were found only during comparisons of homozygotes (additive genetic model with selective/extreme genotypes) in LVM，IVS,LVEDD, LVESD, and LVPWT. Under the dominant model, no significant association was detected between the CYP11B2 -344C/T polymorphism and left ventricular structure. Homozygote/extreme genotypes showed extreme phenotypes,and additive genetic models with selective/extreme genotypes may have more power. The present metaanalysis was also performed using the recessive model (TT+TC vs CC).No significant differenceswere found even in subset analyses. ",
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "The present results have to be interpreted within the context of theirlimitations.First, there was detectable heterogeneityamong studies.To reduce the effectofheterogeneity, studies were regrouped according to covariate regressionanalyses.Anassociationwas foundbetween all five left ventricular structure traitsand CYP11B2-344C/T in some sub-group analyses without heterogeneity $p _ { \\mathrm { h e t e r o } } .$ geneity $> 0 . 0 5$ ). The results of subgroup heterogeneity may be more reliable than the results of the total group with heterogeneity.Second, therewaspublicationbias for studies reported on the association ofLVEDD orLVESD with CYP1lB2-344C/T.Publication bias may lead to overestimation of pooled association between these two traits and CYP11B2-344C/T. Strictly speaking, only the estimations of pooled association on LVM,IVS,and LVPWT were credible.Last,we searched PubMed and Embase databases.Some studies could not be searched in these two databases,including some in local languages,and could not be included in our study.Because of this, the recall ratio of literature retrieval might be affected. ",
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "Through covariate regression analyses under homozygote comparison, sample size,age, sex,patient characteristics,design,DBP,and SBP were found to influence the left ventricular echocardiographic variables in addition to ethnicity. In the table of covariate regression analyses (Table 3),number of participants,age,sex，participant characteristics,year of publication,DBP,and SBP showed significant differences $( p < 0 . 0 5 )$ in at least two left ventricular structure traits out of the five,which indicated that many factors besides ethnicity could also affect the left ventricular structure,and different traits may be affected by different factors. ",
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "In conclusion, the present findings support the hypothesis that CC individuals of rs1799998 may have higherleft ventricular diameter(LVEDD,LVESD) regardless of ethnicity or physical conditions.The same allele (e.g. the C allele of rs1799998) may play different roles in different populations,but this merits deeper study. Confounding factors,such as the sample number,age bracket, sex ratio, characteristics of the participants,year of publication,and BP were found influence to the results of the association analyses ( $\\mathrm { a l l } p < 0 . 0 5$ ） ",
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "List ofabbreviations ",
        "text_level": 1,
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "AF: atrial fibrillation; CVD: cardiovascular diseases; DCM:dilated Cardiomyopathy; EH:essential hypertension; HCM: hypertrophic cardiomyopathy; HF: heart failure;IVS: interventricular septal wall thickness;LVEDD: left ventricular end-diastolic diameter; LVESD:left ventricular end-systolic diameter; LVM: left ventricular mass; LVMI:left ventricular mass index; LVPWT:left ventricular posterior wall thickness；MI: myocardial infarction; NM: normotension; No.: the number of participants in the study; $p _ { \\mathrm { e } }$ : Egger's statisticforpublicationbias; Pheterogenety: the $\\mathcal { Q }$ statistic for heterogeneity; $p _ { \\mathrm { v a l u e } }$ : the statistical significance of the pooled estimate. ",
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "Authors'contributions ",
        "text_level": 1,
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "LWand JZ researched, designed and read through all the research articles.BZ reviewed the reading results.HW,ML and QN extracted and analyzed the data.YC,RC and SW guided the article writing and editing. ",
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "Conflict of interest ",
        "text_level": 1,
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "None declared. ",
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "Funding ",
        "text_level": 1,
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "This work was supported by the Natural Science Foundation of Beijing (grant no.7120001,grant no.7102045), the special fund for overseas talent from Beijing Academy of Science and ",
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "Technology (grant no.OTP-2011-011，grant no.OTP-2012- 011),and the National Natural Science Foundation of China (grant no.81270216). ",
        "page_idx": 12
    },
    {
        "type": "text",
        "text": "References ",
        "text_level": 1,
        "page_idx": 12
    },
    {
        "type": "text",
        "text": "1．De Faire U and Prince J.Genes and environment behind ethnical differences in variations in left ventricular mass. $J$ Hypertens 2004; 22: 241-243.   \n2.Schillaci G,Battista F and Pucci G.A review of the role of electrocardiography in the diagnosis of left ventricular hypertrophy in hypertension. J Electrocardiol 2012；45: 617-623.   \n3． Cuspidi C, Lonati L,Macca G, et al. Prevalence of left ventricular hypertrophy and carotid thickening in a large selected hypertensive population: Impact of different echocardiographic and ultrasonographic diagnostic criteria. Blood Press 2001;10: 142-149.   \n4．Yu Jin, Kuznetsova T,Thijs L,et al. Association of echocardiographic left ventricular structure with the ACE D/I polymorphism: A meta-analysis.J Renin Angiotensin Aldosterone Syst 2011; 12: 243-253.   \n5．Garner C,Lecomte E,Visvikis S,etal.Genetic and environmental influences on left ventricular mass:A family study. Hypertension 2000; 36: 740-746.   \n6.Busjahn A, Li GH, Faulhaber HD,et al. Beta-2 adrenergic receptor gene variations, blood pressure,and heart size in normal twins. Hypertension 2000; 35: 555-560.   \n7．Kupari M,Hautanen A, Lankinen L,et al. Associations between human aldosterone synthase (CYP1lB2) gene polymorphisms and left ventricular size,mass,and function. Circulation 1998; 97: 569-575.   \n8．Delles C,Erdmann J, Jacobi J,et al. Aldosterone synthase (CYP11B2) $- 3 4 4 \\mathrm { C / T }$ polymorphism is associated with left ventricular structure in human arterial hypertension.J Am Coll Cardiol 2001; 37: 878-884.   \n9．Safar ME,Cattan V,Lacolley P,et al.Aldosterone synthase gene polymorphism, stroke volume and age-related changes in aortic pulse wave velocity in subjects with hypertension. JHypertens 2005;23:1159-1166.   \n10． Amir O,Amir RE, Paz H, et al. Aldosterone synthase gene polymorphismas a determinant of atrial fibrillation in patients with heart failure.AmJCardiol 2008;102: 326-329.   \n11．Sun X, Yang J,Hou X,et al. Relationship between -344T/C polymorphism in the aldosterone synthase gene and atrial fibrillation in patients with essential hypertension.J Renin Angiotensin Aldosterone Syst 2011; 12: 557-563.   \n12．Takai E,Akita H, Kanazawa K,et al.Association between aldosterone synthase (CYP11B2） gene polymorphism and left ventricular volume in patients with dilated cardiomyopathy.Heart 2002; 88: 649-650.   \n13．Heller S,Linhart A,Jindra A,et al.Association of 344/T/C aldosterone synthase polymorphism(CYP11B2）with left ventricular structure and humoral parameters in young normotensive men.Blood Pressure 2004; 13:158-163.   \n14．Sookoian S,Gianotti TF and Pirola CJ.Role of the C-344T aldosterone synthase gene variant in left ventricular mass and left ventricular structure-related phenotypes.Heart 2008;94: 903-910.   \n15．Bowden J,Tierney JF,Copas AJ,et al. Quantifying,displaying and accounting for heterogeneity in the meta-analysis of CIs using stanuard and generaiiseu Q statsucs.DMC Meu Res Methodol 2011; 11: 41.   \n16．Bagos PG.Genetic model selection in genome-wide association studies: Robust methods and the use of meta-analysis. Stat Appl Genet Mol Biol 2013; 12: 285-308.   \n17.Chootrakool H, Shi JQ and Yue R.Meta-analysis and sensitivity analysis for multi-arm trials with selection bias.Stat Med 2011; 30: 1183-1198.   \n18.Egger M, Davey Smith G, Schneider M,et al.Bias in metaanalysis detected by a simple,graphical test. BMJ 1997;   \n315: 629-634.   \n19. Stuck AE,Rubenstein LZ and Wieland D.Bias in metaanalysis detected by a simple,graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity.BMJ1998; 316: 469.   \n20．Rao L, Zhang Q, Liang W, et al. Associations between aldosterone synthase gene polymorphisms and left ventricular structure and function in Chinese normal Han people [article in Chinese].SichuanDa Xue XueBao Yi Xue Ban [Journal of West China University of Medical Sciences]   \n2003;34: 1-3.   \n21． Rao L, Zhou B,Wang B,et al. Study on association between aldosterone synthase gene polymorphism and the left ventricular structure and function of patients with dilated cardiomyopathy in China [article in Chinese]. Sichuan Da Xue Xue Bao Yi Xue Ban 2004; 35: 809-811.   \n22．Tamaki S,Iwai N, Tsujita Y,et al. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese.Hypertension   \n1999; 33: 266-270.   \n23．Patel R,Lim DS,Reddy D,et al. Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy.JMol Cell Cardiol 2000; 32:   \n2369-2377.   \n24. Ortlepp JR,Breithardt O,Ohme F,et al. Lack of association among five genetic polymorphisms of the renin-angiotensin system and cardiac hypertrophy in patients with aortic stenosis.Am Heart J2001; 141: 671-676.   \n25.Kurland L,Melhus H, Karlsson J,et al. Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. JHypertens 2002; 20: 657-663.   \n26． Sarzani R, SalviF,Dessi-Fulgheri P,etal.Aldosterone synthase alleles and cardiovascular phenotype in young adults. JHum Hypertens 2003;17: 859-864.   \n27． Stella P,Bigatti G, Tizzoni L,et al. Association between aldosterone synthase (CYP11B2） polymorphism and left ventricular mass in human essential hypertension.JAm Coll Cardiol 2004; 43: 265-270.   \n28．Isaji M,Mune T,Takada N,et al. Correlation between left ventricular mass and urinary sodium excretion in specific genotypes of CYP11B2. J Hypertens 2005； 23:   \n1149-1157.   \n29. Chai W, Hoedemaekers Y,van Schaik RH, et al. Cardiac aldosterone in subjects with hypertrophic cardiomyopathy. JRenin Angiotensin Aldosterone Syst 2006; 7: 225-230.   \n30．Olcay A, Nisanci Y, Ekmekci CG,et al. Aldosterone synthase $- 3 4 4 \\mathrm { C / T }$ and angiotensin-converting enzyme I/D polymorphisms in Turkish hypertensive patients with normal coronarv arteries.Acta Cardiol 2006:61:29-34.   \n31．Bauters C,Lamblin N,Ennezat PV,et al.A prospective evaluation of left ventricular remodeling after inaugural anterior myocardial infarction as a function of gene polymorphisms in the renin-angiotensin-aldosterone,adrenergic,and metalloproteinase systems.Am Heart J2007;153: 64128.   \n32．Schunkert H,Hengstenberg C,Holmer SR,et al.Lack of association between a polymorphism of the aldosterone synthase gene andleft ventricular structure.Circulation 1999; 99:2255-2260.   \n33．Schunkert H,Hengstenberg C,Holmer SR,et al.Evaluation of the aldosterone synthase(CYP11B2) gene polymorphism inpatients with myocardial infarction.Hypertension 2000; 35: 704-709.   \n34． Sia SK,Chiou HL,Chen SC,et al. Distribution and phenotypic expression of mineralocorticoid receptor and CYP11B2 T-344C polymorphisms in a Taiwanese hypertensive population.Mol Biol Rep 2013;40:3705-3711.   \n35.Safar ME,Millasseau S,Mahmud A,et al．Relations between large artery structure and function and aldosterone. JHypertens 2011; 29:1676-1683.   \n36.BrownNJ. Eplerenone:Cardiovascularprotection. Circulation 2003;107:2512-2518.   \n37．Epstein MAldosterone and the hypertensive kidney: Its emerging role asamediator of progressive renal dysfunctionaparadigm shift.JHypertens 2001;19:829-842.   \n38．Rajagopalan S and Pitt B.Aldosterone antagonists in the treatment of hypertension and target organ damage.Curr Hypertens Rep 2001;3:240-248.   \n39．Delyani JA.Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology.Kidney Int 2000; 57:   \n1408-1411.   \n40．Takeda Y,Miyamori I, Yoneda T,etal.Regulation of aldosterone synthase in human vascular endothelial cells by angiotensinIIandadrenocorticotropin.JClin Endocrinol Metab   \n1996;81:2797-2800.   \n41．Takeda Y,Miyamori I, Inaba S,etal.Vascular aldosterone in genetically hypertensive rats.Hypertension 1997;29:45-48.   \n42．Lifton RP,Dluhy RG,Powers M, et al.A chimaeric 11 betahydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature1992;355:262-265.   \n43．Bassett MH, Zhang Y, Clyne C, et al.Differential regulation of aldosterone synthase and11beta-hydroxylase transcription by steroidogenic factor-1.JMol Endocrinol 2002;28:125-135.   \n44.White PC,Hautanen Aand Kupari M.Aldosterone synthase (CYP11B2)polymorphisms and cardiovascular function. $J$ Steroid BiochemMol Biol1999;69:409-412.   \n45．Takeuchi F, Yamamoto K,Katsuya T, et al. Reevaluation of the association of seven candidate genes with blood pressure and hypertension:A replication study and meta-analysis with a larger sample size.Hypertens Res 2012;35:825-831. ",
        "page_idx": 12
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 12
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 13
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 13
    }
]